FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020841613> ?p ?o ?g. }

• W2020841613 endingPage "56" @default.
• W2020841613 startingPage "48" @default.
• W2020841613 abstract "Stuttering is a speech disorder in which the flow of speech is disrupted by repetitions, prolongation, and blocks of sounds, syllables, or words. No pharmacological treatments are approved for use in stuttering, and the most common form of treatment is speech therapy. This study was designed to assess the safety, tolerability, and effectiveness of pagoclone during 8 weeks of double-blind treatment followed by a 1-year open-label extension in patients who stutter.An 8-week, multicenter, parallel-group, 2-arm, randomized (ratio 2:1 pagoclone-placebo), double-blind study with a 1-year open-label extension conducted at 16 US centers, including men and women aged 18 to 65 years who developed stuttering before 8 years of age. Twice-daily dosing with pagoclone (n = 88 patients) or matching placebo (n = 44 patients), with primary and secondary efficacy variables defined a priori, including Stuttering Severity Instrument Version 3 outcomes, clinician global impressions of improvement, and the change in the percentage of syllables stuttered.Pagoclone produced an average 19.4% reduction in percentage of syllables stuttered compared with 5.1% reduction for placebo. During open-label treatment, a 40% reduction in the percent syllables stuttered was observed after 1 year of treatment with pagoclone. The most commonly reported adverse event during double-blind treatment was headache (12.5% pagoclone patients, 6.8% placebo patients).Pagoclone was effective in reducing symptoms of stuttering and was well tolerated. In light of its favorable tolerability profile, as well as consistency of effects across multiple efficacy variables, pagoclone may have potential as a pharmacological treatment of stuttering.The main limitation of this study was the adequacy of the number of subjects who participated because this study was conducted as a pilot investigation. Furthermore, as this condition waxes and wanes, the assessment of stuttering within the clinic setting may not be an adequate reflection of the stuttering of the patients within the community." @default.
• W2020841613 created "2016-06-24" @default.
• W2020841613 creator A5006687757 @default.
• W2020841613 creator A5014310950 @default.
• W2020841613 creator A5018623160 @default.
• W2020841613 creator A5029749927 @default.
• W2020841613 creator A5037354000 @default.
• W2020841613 creator A5040474181 @default.
• W2020841613 creator A5043535417 @default.
• W2020841613 creator A5052470572 @default.
• W2020841613 creator A5064682365 @default.
• W2020841613 creator A5069043909 @default.
• W2020841613 creator A5077932970 @default.
• W2020841613 creator A5085289697 @default.
• W2020841613 creator A5089226873 @default.
• W2020841613 creator A5091143840 @default.
• W2020841613 date "2010-02-01" @default.
• W2020841613 modified "2023-10-17" @default.
• W2020841613 title "Exploratory Randomized Clinical Study of Pagoclone in Persistent Developmental Stuttering" @default.
• W2020841613 cites W1528784932 @default.
• W2020841613 cites W1551785003 @default.
• W2020841613 cites W1965023161 @default.
• W2020841613 cites W1968335983 @default.
• W2020841613 cites W1982243955 @default.
• W2020841613 cites W1982944806 @default.
• W2020841613 cites W1990003238 @default.
• W2020841613 cites W1996398362 @default.
• W2020841613 cites W1998320812 @default.
• W2020841613 cites W2004087971 @default.
• W2020841613 cites W2005754593 @default.
• W2020841613 cites W2006050801 @default.
• W2020841613 cites W2006148157 @default.
• W2020841613 cites W2011815213 @default.
• W2020841613 cites W2014804061 @default.
• W2020841613 cites W2023880677 @default.
• W2020841613 cites W2026616006 @default.
• W2020841613 cites W2042774620 @default.
• W2020841613 cites W2055637612 @default.
• W2020841613 cites W2056940302 @default.
• W2020841613 cites W2057009631 @default.
• W2020841613 cites W2057352190 @default.
• W2020841613 cites W2066799928 @default.
• W2020841613 cites W2093545194 @default.
• W2020841613 cites W2144114111 @default.
• W2020841613 cites W2162002616 @default.
• W2020841613 cites W2188130948 @default.
• W2020841613 cites W2397903832 @default.
• W2020841613 cites W2983721868 @default.
• W2020841613 cites W1992248076 @default.
• W2020841613 doi "https://doi.org/10.1097/jcp.0b013e3181caebbe" @default.
• W2020841613 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20075648" @default.
• W2020841613 hasPublicationYear "2010" @default.
• W2020841613 type Work @default.
• W2020841613 sameAs 2020841613 @default.
• W2020841613 citedByCount "42" @default.
• W2020841613 countsByYear W20208416132012 @default.
• W2020841613 countsByYear W20208416132013 @default.
• W2020841613 countsByYear W20208416132014 @default.
• W2020841613 countsByYear W20208416132015 @default.
• W2020841613 countsByYear W20208416132016 @default.
• W2020841613 countsByYear W20208416132017 @default.
• W2020841613 countsByYear W20208416132018 @default.
• W2020841613 countsByYear W20208416132019 @default.
• W2020841613 countsByYear W20208416132020 @default.
• W2020841613 countsByYear W20208416132021 @default.
• W2020841613 countsByYear W20208416132022 @default.
• W2020841613 countsByYear W20208416132023 @default.
• W2020841613 crossrefType "journal-article" @default.
• W2020841613 hasAuthorship W2020841613A5006687757 @default.
• W2020841613 hasAuthorship W2020841613A5014310950 @default.
• W2020841613 hasAuthorship W2020841613A5018623160 @default.
• W2020841613 hasAuthorship W2020841613A5029749927 @default.
• W2020841613 hasAuthorship W2020841613A5037354000 @default.
• W2020841613 hasAuthorship W2020841613A5040474181 @default.
• W2020841613 hasAuthorship W2020841613A5043535417 @default.
• W2020841613 hasAuthorship W2020841613A5052470572 @default.
• W2020841613 hasAuthorship W2020841613A5064682365 @default.
• W2020841613 hasAuthorship W2020841613A5069043909 @default.
• W2020841613 hasAuthorship W2020841613A5077932970 @default.
• W2020841613 hasAuthorship W2020841613A5085289697 @default.
• W2020841613 hasAuthorship W2020841613A5089226873 @default.
• W2020841613 hasAuthorship W2020841613A5091143840 @default.
• W2020841613 hasConcept C126322002 @default.
• W2020841613 hasConcept C142724271 @default.
• W2020841613 hasConcept C15744967 @default.
• W2020841613 hasConcept C168563851 @default.
• W2020841613 hasConcept C197934379 @default.
• W2020841613 hasConcept C204787440 @default.
• W2020841613 hasConcept C27081682 @default.
• W2020841613 hasConcept C2778375690 @default.
• W2020841613 hasConcept C2781371259 @default.
• W2020841613 hasConcept C548259974 @default.
• W2020841613 hasConcept C71924100 @default.
• W2020841613 hasConceptScore W2020841613C126322002 @default.
• W2020841613 hasConceptScore W2020841613C142724271 @default.
• W2020841613 hasConceptScore W2020841613C15744967 @default.
• W2020841613 hasConceptScore W2020841613C168563851 @default.
• W2020841613 hasConceptScore W2020841613C197934379 @default.

• next